Hyperlipidaemia: Clinical Trials

1 trial for Hyperlipidaemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Hyperlipidaemia: new trials by email Literature Review of Hyperlipidaemia trials Research Report on Hyperlipidaemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia
AZD8233, Placebo - Hyperlipidaemia
Phase 2CompletedAstraZeneca4112021-07-072023-12-15

Narrower conditions

Hyperlipidemias (1)

Broader conditions

Dyslipidemias (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Sponsors

AstraZeneca (1)

Countries

Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Spain (1)  ·  United States (1)